[{"address1": "1300 South El Camino Real", "address2": "Suite 400", "city": "San Mateo", "state": "CA", "zip": "94402", "country": "United States", "phone": "(650) 781-5200", "website": "https://www.kronosbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of therapeutics for various cancer and other serious diseases in the United States. Its lead product candidates are KB-0742, an oral cyclin dependent kinase 9 inhibitor for the treatment of MYC-amplified solid tumors, which is in phase 2 clinical trial; and KB-9558, a core oncogenic transcription factor that drives multiple myeloma. The company was incorporated in 2017 and is headquartered in San Mateo, California.", "fullTimeEmployees": 62, "companyOfficers": [{"maxAge": 1, "name": "Dr. Norbert W. Bischofberger Ph.D.", "age": 67, "title": "President, CEO & Director", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 912200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joshua A. Kazam", "age": 46, "title": "Co-Founder & Director", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 40000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David M. Tanen J.D.", "age": 52, "title": "Secretary & Director", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 40000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Deborah A. Knobelman Ph.D.", "age": 49, "title": "COO & CFO", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Margaux  Bennett Ph.D.", "title": "Vice President of Corporate Development & Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Allison  Frisbee J.D.", "age": 40, "title": "Senior Vice President of Corporate Operations & Legal", "yearBorn": 1983, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Charles  Lin Ph.D.", "age": 38, "title": "Senior Vice President of Research & Development", "yearBorn": 1985, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Elizabeth A. Olek D.O., M.P.H.", "age": 58, "title": "Senior Vice President of Clinical Development", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Wes  Trotter Ph.D.", "title": "Senior Vice President of Drug Discovery & Pharmaceutical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1722470400, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.9981, "open": 1.0, "dayLow": 0.97, "dayHigh": 1.05, "regularMarketPreviousClose": 0.9981, "regularMarketOpen": 1.0, "regularMarketDayLow": 0.97, "regularMarketDayHigh": 1.05, "beta": 1.893, "forwardPE": -0.68986017, "volume": 192390, "regularMarketVolume": 192390, "averageVolume": 372883, "averageVolume10days": 119950, "averageDailyVolume10Day": 119950, "bid": 0.9403, "ask": 1.03, "bidSize": 100, "askSize": 100, "marketCap": 59480624, "fiftyTwoWeekLow": 0.69, "fiftyTwoWeekHigh": 1.62, "priceToSalesTrailing12Months": 7.070925, "fiftyDayAverage": 1.14876, "twoHundredDayAverage": 1.11254, "currency": "USD", "enterpriseValue": -50033368, "floatShares": 42922527, "sharesOutstanding": 60294600, "sharesShort": 718484, "sharesShortPriorMonth": 720220, "sharesShortPreviousMonthDate": 1719532800, "dateShortInterest": 1722384000, "sharesPercentSharesOut": 0.0119, "heldPercentInsiders": 0.26884001, "heldPercentInstitutions": 0.4017, "shortRatio": 3.92, "shortPercentOfFloat": 0.015700001, "impliedSharesOutstanding": 60294600, "bookValue": 2.043, "priceToBook": 0.48286834, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -102851000, "trailingEps": -1.74, "forwardEps": -1.43, "enterpriseToRevenue": -5.948, "enterpriseToEbitda": 0.531, "52WeekChange": -0.35909092, "SandP52WeekChange": 0.24822903, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "KRON", "underlyingSymbol": "KRON", "shortName": "Kronos Bio, Inc.", "longName": "Kronos Bio, Inc.", "firstTradeDateEpochUtc": 1602250200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "6f8f728e-bb6c-3b57-873b-3a705e9ece7a", "messageBoardId": "finmb_559411734", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.9865, "targetHighPrice": 6.0, "targetLowPrice": 2.25, "targetMeanPrice": 4.13, "targetMedianPrice": 4.13, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 136646000, "totalCashPerShare": 2.266, "ebitda": -94241000, "totalDebt": 27132000, "quickRatio": 8.212, "currentRatio": 8.485, "totalRevenue": 8412000, "debtToEquity": 22.032, "revenuePerShare": 0.143, "returnOnAssets": -0.28279, "returnOnEquity": -0.63004, "freeCashflow": -43455876, "operatingCashflow": -87839000, "revenueGrowth": 0.442, "grossMargins": 1.0, "operatingMargins": -6.4899597, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-08-15"}]